Welcome to our dedicated page for Procter & Gamble SEC filings (Ticker: PG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Procter & Gamble Company (PG) files a wide range of documents with the U.S. Securities and Exchange Commission, providing detailed insight into its operations, capital structure, governance, and shareholder policies. As a New York Stock Exchange‑listed issuer with common stock and multiple series of notes registered under Section 12(b) of the Exchange Act, P&G uses SEC filings to report material events, financing activities, executive and director matters, and shareholder meeting results.
Recent Form 8‑K filings illustrate the types of information investors can find. Regulation FD 8‑Ks document quarterly dividend declarations on common stock and ESOP convertible preferred stock, along with the company’s long record of consecutive dividend payments and increases. Other 8‑Ks report underwritten public offerings of U.S. dollar, euro, and pound sterling notes with various maturities, including floating rate notes and fixed‑rate notes issued under a shelf registration statement on Form S‑3, with related legal opinions filed as exhibits.
Additional 8‑Ks address governance topics such as the approval of The Procter & Gamble 2025 Stock and Incentive Compensation Plan, voting results from the Annual Meeting of Shareholders, and retirement announcements for senior executives. Earnings‑related 8‑Ks furnish quarterly results, slides used on earnings calls, and notices of webcasts. Together with the company’s proxy statement on Schedule 14A, these filings give a structured view of P&G’s executive compensation framework, board composition, and strategic priorities.
On this page, Stock Titan provides real‑time access to Procter & Gamble’s SEC filings as they appear on EDGAR, along with AI‑powered summaries to help explain the significance of each document. Users can quickly review annual and quarterly reports, current reports on Form 8‑K, and exhibits related to new debt offerings or compensation plans, as well as monitor items such as dividend announcements and shareholder vote outcomes without reading every page of the underlying filings.
Procter & Gamble Chief Financial Officer Andre Schulten reported several equity transactions dated 12/03/2025 related mainly to restricted stock units (RSUs) and tax withholding. The filing shows common shares withheld to cover taxes on a prior RSU grant, including 715.5 shares, 88.63 shares, and 68.49 shares withheld at a price of $144.35 per share. An RSU-related transaction added 88.63 common shares, leaving him with 53,386.4466 common shares held directly and 6,869.3576 shares held indirectly through a retirement plan trustee.
In derivative securities, Schulten received 33.091 RSUs as dividend equivalents tied to Procter & Gamble common stock and a retirement award of 88.63 RSUs, both delivering shares upon or in connection with retirement under the company’s plans. After these transactions, he beneficially owned 218.7078 RSUs from dividend equivalents and 1,171.37 RSUs under the retirement program.
Procter & Gamble executive Sundar G. Raman reported routine equity transactions and awards involving company stock and restricted stock units. On 12/03/2025, he disposed of 59.43 shares of Procter & Gamble common stock at $144.35 per share to cover taxes on previous restricted stock unit grants, and following these transactions held 41,888.5423 shares directly, plus 8,436.9135 shares held indirectly through a retirement plan trustee.
Separately, he recorded activity in restricted stock units. On 11/17/2025, he acquired 31.6587 dividend-equivalent restricted stock units, bringing his direct restricted stock unit holdings in one line to 246.1457 units. On 12/03/2025, he exercised or converted 59.43 restricted stock units, after which another restricted stock unit holding line totaled 995.57 units. Several of these units are tied to Procter & Gamble’s retirement and deferred compensation programs and generally deliver shares upon retirement, subject to plan terms.
Procter & Gamble’s Chief Human Resources Officer, Balaji Purushothaman, reported routine equity transactions in company stock. On 12/03/2025, 38.27 shares of common stock were acquired through the exercise or settlement of derivative securities at a price of $144.35 per share, and the same 38.27 shares were disposed of to cover tax withholding on a prior restricted stock unit grant.
After these transactions, the reporting person directly owned 12,638.8004 shares of common stock and indirectly owned 5,166.0704 shares through a retirement plan trustee. The filing also shows dividend-equivalent restricted stock units, including a 10.5941-unit award on 11/17/2025, and notes that certain units will deliver in shares upon retirement or may be deferred or settled in cash according to plan formulas.
Procter & Gamble Chief Brand Officer Marc S. Pritchard reported routine equity transactions involving company stock and restricted stock units. On 12/03/2025, he acquired 94.68 shares of Procter & Gamble common stock through the exercise of derivative securities and had 94.68 shares withheld to cover taxes on a prior restricted stock unit grant at a price of $144.35 per share. After these transactions, he directly owned 182,606.5502 shares of common stock, along with additional indirect holdings through his daughters, a retirement plan, and his spouse.
In a separate transaction dated 11/17/2025, Pritchard received 257.5366 restricted stock units as dividend equivalents, bringing one of his restricted stock unit balances to 9,001.9379 units. Another restricted stock unit entry on 12/03/2025 for 94.68 units is described as a retirement award, leaving a balance of 1,158.32 restricted stock units under that program. These restricted stock units represent contingent rights to receive Procter & Gamble common stock or cash, generally deliverable upon retirement or under the company’s retirement and deferred compensation arrangements.
Procter & Gamble executive Freddy Bharucha, CEO - Beauty, reported equity transactions in company stock. On 12/03/2025, 45.32 shares of common stock were acquired following the vesting of Restricted Stock Units at a reference price of $144.35, coded as an "M" transaction. The same number of shares, 45.32, was then withheld in an "F" transaction to cover taxes on a previous Restricted Stock Unit grant, leaving 1,345.0358 shares of common stock held directly.
In addition, Bharucha holds indirect interests, including 5,051.056 shares through a retirement plan trustee and several indirect positions via a spouse and international plans. The filing also shows 586.68 Restricted Stock Units remaining directly owned, which will deliver in shares upon retirement or as otherwise deferred. These transactions reflect routine equity compensation and tax withholding activity rather than open-market buying or selling.
Procter & Gamble executive Jennifer L. Davis, CEO – Health Care, reported equity transactions in company stock. On 12/03/2025, she acquired 60.43 shares of common stock through an exercise coded “M,” and the same number of shares, 60.43, was withheld in a transaction coded “F” to cover taxes from a prior restricted stock unit grant.
After these transactions, Davis directly owned 61,768.0786 shares of Procter & Gamble common stock and indirectly owned 15,535.3029 shares through a retirement plan trustee. She also reported restricted stock units, including 33.9576 RSUs credited as dividend equivalents and a retirement-related RSU award of 60.43 units, which together left her with 262.6603 and 965.57 RSUs, respectively, subject to delivery terms tied to retirement and the company’s benefit formulas.
Procter & Gamble executive Ma. Fatima Francisco, CEO of the Baby, Fem & Family Care unit, reported equity transactions in a Form 4. On 12/03/2025, she acquired 73.53 shares of common stock through the exercise of restricted stock units at a price of $144.35 per share, with an equal 73.53 shares withheld to cover taxes on a prior restricted stock unit grant. Following these transactions, she directly owned 14,644.7298 common shares, with additional indirect holdings through retirement plan trustees, her spouse, and a SLAT.
In Table II, she reported restricted stock units, including 62.542 units credited as dividend equivalents on 11/17/2025 and 73.53 units settled on 12/03/2025. These units generally represent contingent rights to receive Procter & Gamble common stock, typically delivering in shares upon retirement under the company’s retirement and deferred compensation programs.
Procter & Gamble officer Aguilar Moses, the company’s Chief Research, Development & Innovation Officer, reported several equity transactions in Procter & Gamble common stock on 12/03/2025. The filing shows multiple tax-withholding transactions (coded “F”) where shares such as 221.09, 55.4, 1,076.71 and 60.43 were withheld at a price of $144.35 per share to cover taxes on restricted stock unit grants. One transaction coded “M” reflects the settlement of 55.4 restricted stock units into common shares.
After these transactions, Moses directly owned 44,735.4826 shares of common stock and also had indirect ownership of 6,808.4349 shares through a retirement plan trustee and 428.6033 shares through an international stock ownership plan trustee. The filing also reports restricted stock units, including 19.6192 units credited as dividend equivalents on 11/17/2025 and a retirement award, which will generally deliver Procter & Gamble common stock or cash upon retirement under the company’s benefit formulas.
Procter & Gamble senior executive reports small share withholding for taxes. The company’s SVP and Chief Accounting Officer filed a Form 4 after 14.1 shares of Procter & Gamble common stock were withheld on 12/03/2025 to cover taxes on a previous restricted stock unit grant at a price of $144.35 per share. After this tax-related transaction, the executive directly beneficially owns 971.8749 shares of Procter & Gamble common stock and indirectly owns an additional 3,293.5342 shares through a retirement plan trustee. The filing reflects routine equity compensation and tax withholding activity rather than an open-market buy or sell decision.
Procter & Gamble’s Chief Operating Officer and director Shailesh Jejurikar reported equity transactions involving company stock and restricted stock units. On 12/03/2025, he acquired 51.37 shares of common stock through an option or unit exercise at a price of $144.35 per share, then had 51.37 shares and an additional 279 shares withheld to cover taxes on prior restricted stock unit grants at the same price.
After these transactions, he directly owned 28,800.3765 shares of common stock, plus indirect holdings of 3,331.1419 shares through a retirement plan trustee and 19,757 and 35,836 shares through personal trusts. In the derivative table, dividend-equivalent restricted stock units added 42.3852 units on 11/17/2025, and an RSU-related transaction for 51.37 units on 12/03/2025 left him with 673.63 restricted stock units beneficially owned.
FAQ
What is the current stock price of Procter & Gamble (PG)?
What is the market cap of Procter & Gamble (PG)?
